Incidental benefits after fecal microbiota transplant for ulcerative colitis

Gut dysbiosis can result in several diseases, including infections (Clostridium difficile infection and infectious gastroenteritis), autoimmune diseases (inflammatory bowel disease, diabetes, and allergic disorders), behavioral disorders and other conditions like metabolic syndrome and functional ga...

Full description

Bibliographic Details
Main Authors: Ramit Mahajan, Vandana Midha, Arshdeep Singh, Varun Mehta, Yogesh Gupta, Kirandeep Kaur, Ritu Sudhakar, Anmol Singh Pannu, Dharmatma Singh, Ajit Sood
Format: Article
Language:English
Published: Korean Association for the Study of Intestinal Diseases 2020-07-01
Series:Intestinal Research
Subjects:
Online Access:http://www.irjournal.org/upload/pdf/ir-2019-00108.pdf
_version_ 1818190408939732992
author Ramit Mahajan
Vandana Midha
Arshdeep Singh
Varun Mehta
Yogesh Gupta
Kirandeep Kaur
Ritu Sudhakar
Anmol Singh Pannu
Dharmatma Singh
Ajit Sood
author_facet Ramit Mahajan
Vandana Midha
Arshdeep Singh
Varun Mehta
Yogesh Gupta
Kirandeep Kaur
Ritu Sudhakar
Anmol Singh Pannu
Dharmatma Singh
Ajit Sood
author_sort Ramit Mahajan
collection DOAJ
description Gut dysbiosis can result in several diseases, including infections (Clostridium difficile infection and infectious gastroenteritis), autoimmune diseases (inflammatory bowel disease, diabetes, and allergic disorders), behavioral disorders and other conditions like metabolic syndrome and functional gastrointestinal disorders. Amongst various therapies targeting gut microbiome, fecal microbiota transplantation (FMT) is becoming a focus in the public media and peer reviewed literature. We have been using FMT for induction of remission in patients with moderate to severe active ulcerative colitis (UC) and also for subsequent maintenance of remission. Four cases reported incidental benefits while being treated with FMT for UC. These included weight loss (n=1), improvement in hair loss (n=1), amelioration of axial arthritis (n=1) and improvement in allergic rhinitis (n=1), thereby suggesting potential clinical applications of FMT in treating extraintestinal diseases associated with gut dysbiosis.
first_indexed 2024-12-11T23:58:15Z
format Article
id doaj.art-04a5fb3e404d4f628183e2a275743080
institution Directory Open Access Journal
issn 1598-9100
2288-1956
language English
last_indexed 2024-12-11T23:58:15Z
publishDate 2020-07-01
publisher Korean Association for the Study of Intestinal Diseases
record_format Article
series Intestinal Research
spelling doaj.art-04a5fb3e404d4f628183e2a2757430802022-12-22T00:45:18ZengKorean Association for the Study of Intestinal DiseasesIntestinal Research1598-91002288-19562020-07-0118333734010.5217/ir.2019.00108832Incidental benefits after fecal microbiota transplant for ulcerative colitisRamit Mahajan0Vandana Midha1Arshdeep Singh2Varun Mehta3Yogesh Gupta4Kirandeep Kaur5Ritu Sudhakar6Anmol Singh Pannu7Dharmatma Singh8Ajit Sood9 Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India Department of Internal Medicine, Dayanand Medical College and Hospital, Ludhiana, India Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India Department of Pharmacology, Dayanand Medical College and Hospital, Ludhiana, India Department of Dietetics, Dayanand Medical College and Hospital, Ludhiana, India Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, IndiaGut dysbiosis can result in several diseases, including infections (Clostridium difficile infection and infectious gastroenteritis), autoimmune diseases (inflammatory bowel disease, diabetes, and allergic disorders), behavioral disorders and other conditions like metabolic syndrome and functional gastrointestinal disorders. Amongst various therapies targeting gut microbiome, fecal microbiota transplantation (FMT) is becoming a focus in the public media and peer reviewed literature. We have been using FMT for induction of remission in patients with moderate to severe active ulcerative colitis (UC) and also for subsequent maintenance of remission. Four cases reported incidental benefits while being treated with FMT for UC. These included weight loss (n=1), improvement in hair loss (n=1), amelioration of axial arthritis (n=1) and improvement in allergic rhinitis (n=1), thereby suggesting potential clinical applications of FMT in treating extraintestinal diseases associated with gut dysbiosis.http://www.irjournal.org/upload/pdf/ir-2019-00108.pdffecal microbiota transplantationcolitis, ulcerativeincidental findings
spellingShingle Ramit Mahajan
Vandana Midha
Arshdeep Singh
Varun Mehta
Yogesh Gupta
Kirandeep Kaur
Ritu Sudhakar
Anmol Singh Pannu
Dharmatma Singh
Ajit Sood
Incidental benefits after fecal microbiota transplant for ulcerative colitis
Intestinal Research
fecal microbiota transplantation
colitis, ulcerative
incidental findings
title Incidental benefits after fecal microbiota transplant for ulcerative colitis
title_full Incidental benefits after fecal microbiota transplant for ulcerative colitis
title_fullStr Incidental benefits after fecal microbiota transplant for ulcerative colitis
title_full_unstemmed Incidental benefits after fecal microbiota transplant for ulcerative colitis
title_short Incidental benefits after fecal microbiota transplant for ulcerative colitis
title_sort incidental benefits after fecal microbiota transplant for ulcerative colitis
topic fecal microbiota transplantation
colitis, ulcerative
incidental findings
url http://www.irjournal.org/upload/pdf/ir-2019-00108.pdf
work_keys_str_mv AT ramitmahajan incidentalbenefitsafterfecalmicrobiotatransplantforulcerativecolitis
AT vandanamidha incidentalbenefitsafterfecalmicrobiotatransplantforulcerativecolitis
AT arshdeepsingh incidentalbenefitsafterfecalmicrobiotatransplantforulcerativecolitis
AT varunmehta incidentalbenefitsafterfecalmicrobiotatransplantforulcerativecolitis
AT yogeshgupta incidentalbenefitsafterfecalmicrobiotatransplantforulcerativecolitis
AT kirandeepkaur incidentalbenefitsafterfecalmicrobiotatransplantforulcerativecolitis
AT ritusudhakar incidentalbenefitsafterfecalmicrobiotatransplantforulcerativecolitis
AT anmolsinghpannu incidentalbenefitsafterfecalmicrobiotatransplantforulcerativecolitis
AT dharmatmasingh incidentalbenefitsafterfecalmicrobiotatransplantforulcerativecolitis
AT ajitsood incidentalbenefitsafterfecalmicrobiotatransplantforulcerativecolitis